Small molecule protein degraders are set to reshape the way by which diseases will be treated. Our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. Headquartered in Boston with additional laboratory facilities in Basel, Monte Rosa Therapeutics is a private company launched in 2020.

Profile

Social Media

Monte Rosa Therapeutics Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Markus Warmuth

Chief Financial Officer

Ajim Tamboli

Chief Scientific Officer

John Castle

Chief Scientific Officer

Owen Wallace

Vice President

Silvia Buonamici

Vice President

Alexander Flohr

Vice President

Giorgio Ottaviani

VP - Bus. Development

Jullian Jones

Browse more venture capital transactions:

Prev: 3/15/2021: Nimble Robotics venture capital transaction
Next: 3/15/2021: Disruptel venture capital transaction

Share this article

Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary